搜索临床试验以：免疫调节剂于 2023 年 1 月 1 日获得 FDA 批准。
总计10个结果
-
American Thrombosis and Hemostasis NetworkBayer; Shire; CSL Behring; Bioverativ Therapeutics Inc.完全的
-
NeuroWave Systems Inc.Fraser Health; U.S. Army Medical Research Acquisition Activity完全的
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; Weill Medical College of Cornell University完全的
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of Virginia完全的